within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AC19_Beraprost;
model Beraprost 
   extends Pharmacolibrary.Drugs.ATC.B.B01AC19;

  annotation(Documentation(
    info ="<html><body><p>Beraprost is an orally active prostacyclin analog used primarily as a vasodilator for the treatment of pulmonary arterial hypertension (PAH) and peripheral arterial disease. It acts by inhibiting platelet aggregation and inducing vasodilation. While approved for use in Japan and some Asian countries, it is not currently approved by the US FDA or EMA.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after a single oral dose</p><h4>References</h4><ol><li><p>Shimamura, M, et al., &amp; Miyamoto, Y (2017). The Pharmacokinetics of Beraprost Sodium Following Single Oral Administration to Subjects With Impaired Kidney Function. <i>Journal of clinical pharmacology</i> 57(4) 524–535. DOI:<a href=&quot;https://doi.org/10.1002/jcph.835&quot;>10.1002/jcph.835</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27681484/&quot;>https://pubmed.ncbi.nlm.nih.gov/27681484</a></p></li><li><p>Demolis, JL, et al., &amp; Jaillon, P (1993). Pharmacokinetics and platelet antiaggregating effects of beraprost, an oral stable prostacyclin analogue, in healthy volunteers. <i>Journal of cardiovascular pharmacology</i> 22(5) 711–716. DOI:<a href=&quot;https://doi.org/10.1097/00005344-199311000-00007&quot;>10.1097/00005344-199311000-00007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7506323/&quot;>https://pubmed.ncbi.nlm.nih.gov/7506323</a></p></li><li><p>Nakajo, I, et al., &amp; Shiramoto, M (2021). Comparison of Pharmacokinetic Profiles of Beraprost Sustained Release in Japanese, Chinese, and Korean Healthy Adult Males. <i>Clinical drug investigation</i> 41(6) 549–555. DOI:<a href=&quot;https://doi.org/10.1007/s40261-021-01031-8&quot;>10.1007/s40261-021-01031-8</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33913081/&quot;>https://pubmed.ncbi.nlm.nih.gov/33913081</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Beraprost;
